miR-155 as a Biomarker in B-Cell Malignancies

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• MicroRNAs are key regulators of cellular processes and potential biomarkers for cancer.
• miR-155 is implicated as an oncomiR in the development of B-cell malignancies.

Purpose of the Study:

• To review the potential of miR-155 as a diagnostic, prognostic, and predictive biomarker in B-cell malignancies.
• To explore miR-155 as a therapeutic target for personalized cancer treatment.

Main Methods:

• Systematic literature search to identify relevant studies on miR-155 in B-cell malignancies.
• Analysis of existing in vitro and in vivo data regarding miR-155 expression and function.

Main Results:

• miR-155 is upregulated in various B-cell malignancies compared to nonmalignant controls.
• Overexpression of miR-155 correlates with poorer prognosis in these cancers.
• Elevated miR-155 shows diagnostic and prognostic potential in diffuse large B-cell lymphoma and chronic lymphocytic leukemia.

Conclusions:

• miR-155 holds significant potential as a molecular tool for personalized medicine in B-cell malignancies.
• Inhibiting miR-155 with anti-miR structures presents a promising therapeutic strategy.
• Further research supports miR-155's role in oncogenesis and its utility as a therapeutic target.